{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:09:08Z","timestamp":1777478948394,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cSirius\u201d Federal Territory\u201d Scientific and technological development of the \u201cSirius\u201d Federal Territory\u201d","award":["18-03"],"award-info":[{"award-number":["18-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hemophilia B is a hereditary bleeding disorder caused by mutations localized throughout the F9 gene. Existing gene therapy products containing AAV vectors have significant limitations. Replacement therapy with coagulation factor FIX infusions is not an optimal way of treatment, as patients still have periodic bleeding and require frequent transfusions. Moreover, approximately 5% of adult patients with hemophilia B develop inhibitory antibodies to recombinant forms of FIX. Therefore, it is important to develop universal CRISPR\/Cas gene therapy approaches for F9 editing using non-viral delivery systems to enable gene reversion to a functional sequence at an early stage of disease development and establishment of the patients\u2019 immune system. In this study, a unique approach of F9 prime-editing was tested for the first time. This method is estimated to edit 7.3% of pathogenic F9 mutation types. Specifically, it targets the gene region encoding amino acids 374 V to 408 Q, which accounts for approximately 9.35% of patients with hemophilia B. An advantage of this gene therapy approach is the absence of the need to change Primer Binding Site (PBS) or Reverse Transcriptase Template (RTT) sequences until going from preclinical to clinical trials, as well as the introduction of gain of function mutations in order to compensate for the low prime-editing frequencies and enhance the effect of treatment in vivo.<\/jats:p>","DOI":"10.3390\/ijms262411916","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:32:17Z","timestamp":1765380737000},"page":"11916","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Template-Jumping Editing Approach in F9-Associated Hemophilia B Gene Therapy"],"prefix":"10.3390","volume":"26","author":[{"given":"Robert","family":"Sattarov","sequence":"first","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Kuznetsov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriy","family":"Klimko","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-6562","authenticated-orcid":false,"given":"Elena","family":"Ignatyeva","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4183","authenticated-orcid":false,"given":"Roman","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-5182","authenticated-orcid":false,"given":"Alexander","family":"Karabelsky","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3568-9296","authenticated-orcid":false,"given":"Anastasia","family":"Fizikova","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd Edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Hemophilia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: Molecular Pathogenesis and Mutation Analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_3","first-page":"466","article-title":"Mutational Analysis of Hemophilia B in Russia: Molecular-Genetic Study","volume":"52","author":"Surin","year":"2016","journal-title":"Genetika"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex Genome Engineering Using CRISPR\/Cas Systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.dnarep.2008.06.018","article-title":"Comparison of Nonhomologous End Joining and Homologous Recombination in Human Cells","volume":"7","author":"Mao","year":"2008","journal-title":"DNA Repair."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41598-017-04625-5","article-title":"CRISPR\/Cas9-Mediated Genome Editing via Postnatal Administration of AAV Vector Cures Hemophilia B Mice","volume":"7","author":"Ohmori","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chernyi, N., Gavrilova, D., Saruhanyan, M., Oloruntimehin, E.S., Karabelsky, A., Bezsonov, E., and Malogolovkin, A. (2024). Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives. Biomolecules, 14.","DOI":"10.3390\/biom14070854"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-023-39137-6","article-title":"Template-Jumping Prime Editing Enables Large Insertion and Exon Rewriting in Vivo","volume":"14","author":"Zheng","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41467-022-28442-1","article-title":"Prime Editing Efficiency and Fidelity Are Enhanced in the Absence of Mismatch Repair","volume":"13","author":"Oliveira","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1016\/j.cell.2025.07.010","article-title":"AI-Generated MLH1 Small Binder Improves Prime Editing Efficiency","volume":"188","author":"Park","year":"2025","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Colon Cancer Family Registry, Dowty, J., Win, A., Buchanan, D., Macinnis, R., Lindor, N., Thibodeau, S., Casey, G., Gallinger, S., and LeMarchand, L. (2012). Substantial Unexplained Variation in Cancer Risks for MLH1 and MSH2 Mutation Carriers. Hered. Cancer Clin. Pract., 10, A33.","DOI":"10.1186\/1897-4287-10-S2-A33"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.omtm.2020.03.013","article-title":"Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release","volume":"17","author":"Lengler","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mt.2013.188","article-title":"Integration-Deficient Lentiviral Vectors Expressing Codon-Optimized R338L Human FIX Restore Normal Hemostasis in Hemophilia B Mice","volume":"22","author":"Suwanmanee","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_15","unstructured":"(2024, November 05). Factor IX Gene (F9) Variant Database. Available online: https:\/\/www.factorix.org\/mut_map.html.php."},{"key":"ref_16","unstructured":"Alshaikhli, A., Killeen, R.B., Rokkam, V.R., and Hemophilia, B. (2025). StatPearls, StatPearls Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00340","DOI":"10.1042\/BSR20160098","article-title":"The First EGF Domain of Coagulation Factor IX Attenuates Cell Adhesion and Induces Apoptosis","volume":"36","author":"Ishikawa","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41419-022-04569-3","article-title":"Genome Wide CRISPR\/Cas9 Screen Identifies the Coagulation Factor IX (F9) as a Regulator of Senescence","volume":"13","author":"Borghesan","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/jacsau.4c00138","article-title":"CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets","volume":"4","author":"Zhang","year":"2024","journal-title":"JACS Au"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101103","DOI":"10.1016\/j.drup.2024.101103","article-title":"Mechanisms of Sensitivity and Resistance to CDK4\/CDK6 Inhibitors in Hormone Receptor-Positive Breast Cancer Treatment","volume":"76","author":"Glaviano","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"ref_21","unstructured":"(2025, November 03). FunCoup Functional Coupling, or Functional Association Framework. Available online: https:\/\/funcoup.org\/uniprot\/P00740\/."},{"key":"ref_22","unstructured":"(2025, November 03). The IntAct Database of Evidence for Molecular Interactions. Available online: https:\/\/www.ebi.ac.uk\/intact\/search?query=id:P00740*#interactor\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","article-title":"Functional Roles of Human Kallikrein-Related Peptidases","volume":"284","author":"Sotiropoulou","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10760296241275454","DOI":"10.1177\/10760296241275454","article-title":"Study on the Mutation of F\u2168 Gene in 31 Patients with Type B Hemophilia","volume":"30","author":"Liu","year":"2024","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_25","first-page":"28","article-title":"The spectrum of the F9 gene mutations in Russian patients with hemophilia B. Nauchno-Prakt","volume":"21","author":"Beskorovainaya","year":"2022","journal-title":"Zhurnal Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome Engineering Using the CRISPR\/Cas9 System","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: Intuitive Guide Selection for CRISPR\/Cas9 Genome Editing Experiments and Screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"W499","DOI":"10.1093\/nar\/gkab319","article-title":"PE-Designer and PE-Analyzer: Web-Based Design and Analysis Tools for CRISPR Prime Editing","volume":"49","author":"Hwang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109700","DOI":"10.1016\/j.celrep.2021.109700","article-title":"Multiplexed Drug-Based Selection and Counterselection Genetic Manipulations in Drosophila","volume":"36","author":"Matinyan","year":"2021","journal-title":"Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1590\/S0004-27302005000600019","article-title":"Padroniza\u00e7\u00e3o Da T\u00e9cnica de Extra\u00e7\u00e3o de DNA de C\u00e9lulas de Mucosa Oral Com NaCl: Aplica\u00e7\u00e3o No Estudo Do Gene PROP1","volume":"49","author":"Billerbeck","year":"2005","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy Quantitative Assessment of Genome Editing by Sequence Trace Decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_32","unstructured":"(2025, May 05). ICE CRISPR Analysis. 2025. v3.0. EditCo Bio. Available online: https:\/\/ice.editco.bio."},{"key":"ref_33","unstructured":"(2025, June 10). Free Statistics App. Available online: https:\/\/statisty.app\/."},{"key":"ref_34","unstructured":"Altman, D., Machin, D., Bryant, T., and Gardner, M.J. (2013). Statistics with Confidence: Confidence Intervals and Statistical Guidelines, Wiley. [2nd ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/sim.4116","article-title":"The Analysis of 2 \u00d7 2 Contingency Tables\u2014Yet Again","volume":"30","author":"Richardson","year":"2011","journal-title":"Stat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.2832","article-title":"Chi-squared and Fisher\u2013Irwin Tests of Two-by-two Tables with Small Sample Recommendations","volume":"26","author":"Campbell","year":"2007","journal-title":"Stat. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11916\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:31:02Z","timestamp":1765528262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":36,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262411916"],"URL":"https:\/\/doi.org\/10.3390\/ijms262411916","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}